Myriad Genetics Inc (MYGN)

Depreciation & Amortization

$12.50M

Quarterly · Period ending: · USD

MYGN logo

MYGN Depreciation & Amortization

Latest reported$12.50M
MYGN Quarterly Depreciation & Amortization ($400.00K → $12.50M)
High-resolution chart · PNG

MYGN depreciation & amortization history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Myriad Genetics Inc Depreciation & Amortization — Quarterly (USD)
Period endingDepreciation & Amortization (USD)
12,500,000
12,500,000
12,600,000
12,600,000
14,100,000
14,400,000
14,800,000
15,600,000
15,100,000
15,700,000
15,100,000
14,100,000
13,300,000
19,400,000
13,700,000
13,100,000
12,900,000
13,000,000
13,300,000
14,200,000
16,900,000
18,400,000
18,100,000
17,700,000
17,700,000
17,900,000
18,200,000
18,200,000
18,400,000
18,300,000
18,000,000
18,300,000
15,100,000
13,000,000
13,100,000
13,200,000
13,300,000
12,900,000
12,900,000
9,200,000
6,700,000
6,500,000
6,700,000
6,800,000
6,611,000
6,400,000
6,000,000
6,000,000
5,528,000
3,480,000
2,439,000
2,372,000
2,254,000
2,180,000
2,244,000
2,211,000
2,328,000
2,303,000
2,291,000
2,147,000
1,878,000
1,800,000
1,784,000
1,757,000
1,792,000
1,778,000
1,735,000
1,779,000
2,439,000
2,408,000
2,346,000
2,256,000
2,259,000
2,287,000
2,167,000
2,068,000
2,008,000
1,955,000
1,824,000
1,757,000
1,804,000
1,717,000
1,691,000
1,643,000
1,546,000
1,523,000
1,537,000
1,486,000
1,459,000
1,453,000
1,435,000
1,419,000
1,306,000
1,294,000
1,379,000
1,296,000
1,220,873
1,208,558
1,024,715
1,042,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.